Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Global Human Chorionic Gonadotropin Market, by Therapeutic Area, 2015 (USD Mn)
2.2 Global Human Chorionic Gonadotropin Market, by Technology, 2015 (USD Mn)
2.3 Global Human Chorionic Gonadotropin Market, by Therapeutic Area Market, by Geography, 2015 (Value %)
Chapter 3 Global Hematopoietic Stem Cells Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 High Infertility Prevalence Worldwide
3.3 Market Restraints
3.3.1 Availability of Substitutes
3.4 Market Opportunities
3.4.1 Demand for Recombinant HCG
3.5 Attractive Investment Proposition
3.6 Market Competition Assessment: Human Chorionic Gonadotropin Market, by Key Players
Chapter 4 Global Human Chorionic Gonadotropin Market Analysis, By Treatment
4.1 Overview
4.2 Female Infertility Treatment
4.3 Oligospermia Treatment
4.4 Cryptorchidism Treatment
4.5 Others
Chapter 5 Global Human Chorionic Gonadotropin Market Analysis, By Technology
5.1 Overview
5.2 Natural Source Extraction
5.3 Recombinant DNA Technology
Chapter 6 Global Human Chorionic Gonadotropin Market, By Geography
6.1 Preface
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Latin America
6.6 Middle East and Africa
Chapter 7 Company Profiles
7.1 Ferring B.V.
7.1.1 Ferring B.V.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.2 Bristol-Myers Squibb Company
7.2.1 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.3 EMD Serono, Inc.
7.3.1 EMD Serono, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.4 Fresenius Kabi USA, LLC
7.4.1 Fresenius Kabi USA, LLC: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
7.5 Merck & Co., Inc.
7.5.1 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
List of Figures
FIG. 1 Human Chorionic Gonadotropin Market: Research Methodology
FIG. 2 Global Human Chorionic Gonadotropin Market, by Therapeutic Area, 2015 (USD Mn)
FIG. 3 Global Human Chorionic Gonadotropin Market, by Technology, 2015 v/s 2022 (Value %)
FIG. 4 Global Human Chorionic Gonadotropin Market, by Geography, 2015 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography, 2015
FIG. 6 HCG Market in Female Infertility Treatment, 2014 – 2022 (USD Mn)
FIG. 7 HCG Market in Oligospermia Treatment, 2014 – 2022 (USD Mn)
FIG. 8 HCG Market in Cryptorchidism Treatment, 2014 – 2022 (USD Mn)
FIG. 9 HCG Market in Other Treatments, 2014 – 2022 (USD Mn)
FIG. 10 HCG from Natural Source Extraction Market, 2014 – 2022 (USD Mn)
FIG. 11 HCG from Recombinant DNA Technology Market, 2014 – 2022 (USD Mn)
FIG. 12 North America Human Chorionic Gonadotropin Market, By Country, 2013 – 2022 (USD Mn)
FIG. 13 Europe Hematopoietic Stem Cell Transplant Market , 2013 – 2022 (USD Mn)
FIG. 14 Asia-Pacific Human Chorionic Gonadotropin Market , 2013 – 2022 (USD Mn)
FIG. 15 Latin America Human Chorionic Gonadotropin Market, 2016 – 2022 (USD Mn)
FIG. 16 Middle East and Africa Human Chorionic Gonadotropin Market, 2016 – 2022 (USD Mn)
List of Tables
TABLE 1 Therapeutics Category
TABLE 2 Market Competition Assessment: Human Chorionic Gonadotropin Products, by Key Players
TABLE 3 Global Human Chorionic Gonadotropin Market, by Treatment, 2014-2022 (USD Mn)
TABLE 4 Global Human Chorionic Gonadotropin Market, by Technology, 2014-2022 (USD Mn)
TABLE 5 Global Human Chorionic Gonadotropin Market, by Geography, 2016 – 2022 (USD Mn)
TABLE 6 Ferring B.V.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 7 Bristol-Myers Squibb Company: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 8 EMD Serono, Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 9 Fresenius Kabi USA, LLC: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)
TABLE 10 Merck & Co., Inc.: Company Snapshot (Business Description; Financial Health and Budget Allocation; Product Position/Portfolio; News Coverage)